ImmunityBio is dedicated to conquering cancer. We develop therapies that kill disease, not the immune system. Learn about our investigational immunotherapy and cell therapy products.
Employees: 51-200
Founded date: 2002
Investors 1
| Date | Name | Website |
| - | Avoro Capi... | avorocapit... |
Mentions in press and media 9
| Date | Title | Description | Source |
| 23.11.2020 | Drugmakers behind 3 coronavirus vaccines say they work. Here... | A pharmacist gives Jennifer Haller, left, the first shot in the first-stage safety study clinical tr... | businessin... |
| 08.01.2020 | At 2020 deadline, progress in Patrick Soon-Shiong’s ‘cancer ... | In 2016, the biotech billionaire Dr. Patrick Soon-Shiong set himself a deadline: By 2020, he would t... | statnews.c... |
| 26.03.2019 | NantKWest Raises $39 Million From Company Founder Patrick So... | - | labusiness... |
| 06.02.2018 | New Union-Tribune owner ambitious, controversial | Patrick Soon-Shiong, the billionaire medical entrepreneur who this morning has agreed to buy the Los... | sandiegoun... |
| 06.04.2017 | Viracta Therapeutics Holds Initial Close of Series B Funding... | Viracta Therapeutics, Inc., a San Diego, CA-based clinical-stage drug development company, held the ... | finsmes.co... |
| 27.03.2017 | Soon-Shiong’s promotion of ‘breakthrough’ cancer therapy rai... | The emotional video tells of a patient with blood cancer who tries an experimental therapy involving... | statnews.c... |
| 29.06.2016 | The biotech IPO feast flags as investors lose their appeti... | There was a time after the 2008 crash that biotech IPOs were about as popular as snow in March. B... | endpts.com... |
| 29.11.2015 | NantHealth to delay IPO in face of tough market | NantHealth, the health IT and analytics branch of Dr. Patrick Soon-Shiong‘s NantWorks conglomerate, ... | medcitynew... |
| - | NantHealth to delay IPO in face of tough market | NantHealth, the health IT and analytics branch of Dr. Patrick Soon-Shiong‘s NantWorks conglomerate, ... | medcitynew... |